Biotechnology Industry and Peptech
17 search results

Highlights this month

On the move in Taiwan, supported by strong government funding ...

Biotechnology to Taiwan - For Australian exporters - Austrade

While the biotechnology industry is on the move in Taiwan, supported by strong government funding and private sector interest, there are some inherent weaknesses that provide opportunities for Australia. The ...

Federal Government - 4 months, 1 week ago
Receive a boost from targeted training by Southbank Institute of ...

Southbank course to lift biotechnology skills

Queensland's rapidly growing biotechnology industry will receive a boost from targeted training by Southbank Institute of Technology and subsidised cadetships to help overcome skills shortages. Education and Training Minister Rod ...

QLD State Government - 10 months, 2 weeks ago
Been boosted with the opening of a sterile laboratory at ...

New sterile lab a boost for cell therapy research

Western Australia's biotechnology industry has been boosted with the opening of a sterile laboratory at Murdoch University.

ABC Science - 1 year, 5 months ago
Doubled in recent years, Minster for State Development John Mickel ...

MICKEL CONGRATULATES BIOTECH CEOS FOR BOOM IN INDUSTRY

An industry survey has shown employment in the Australian biotechnology industry has doubled in recent years, Minster for State Development John Mickel told delegates at the 2007 AusBiotech CEO Forum ...

QLD State Government - 1 year, 8 months ago

1 year, 3 months ago EvoGenix, Peptech merger gets shareholder vote

EVOGENIX shareholders have voted in favour of the merger between Peptech and EvoGenix, creating one of the biggest biotechnology companies in Australia.
Adelaide Now - 3:08 p.m. Thursday 9th August 2007

Coverage & Analysis View Article Email to Friend

EvoGenix shareholders back Peptech deal

A merger between drug maker Peptech Ltd and rival EvoGenix Ltd has received the unanimous support of EvoGenix Shareholders, creating one of the biggest biotechnology companies in Australia.Under the $156 ...
ninemsn Business News - 3:07 p.m. Thursday 9th August 2007

Coverage & Analysis View Article Email to Friend

Peptech, EvoGenix merger 'needs big sell'

IT'S being billed as a marriage made in heaven, but biotech company Peptech's buyout of EvoGenix has failed to attract the interest of small investors, their respective chief executives have ...
News Ltd Markets - 4:05 p.m. Monday 9th July 2007

Coverage & Analysis View Article Email to Friend

Peptech-EvoGenix merger faces big sell

It's being billed as a marriage made in heaven, but biotech company Peptech's buyout of EvoGenix has failed to attract the interest of small investors.
Yahoo!7 Finance News - 3:36 p.m. Monday 9th July 2007

Coverage & Analysis View Article Email to Friend

1 year, 5 months ago Peptech chairman Mel Bridges to step down after merger

Peptech chairman Mel Bridges has announced he would step down from the board, but only after the $156 million merger with fellow biotech EvoGenix was completed.
Sydney Morning Herald Business - 2:35 p.m. Tuesday 26th June 2007

Coverage & Analysis View Article Email to Friend

1 year, 6 months ago Peptech clinical first

AUSTRALIAN biotech Peptech has launched a clinical trial for a drug aimed at treating inflammatory diseases like rheumatoid arthritis.
Adelaide Now - 12:27 a.m. Wednesday 23rd May 2007

Coverage & Analysis View Article Email to Friend

1 year, 6 months ago Peptech trials arthritis treatment drug

Australian biotech company Peptech has launched a clinical trial for a drug aimed at treating inflammatory diseases like rheumatoid arthritis.
Yahoo!7 Finance News - 10:28 a.m. Tuesday 22nd May 2007

Coverage & Analysis View Article Email to Friend

1 year, 6 months ago Peptech clocks 2,415% jump in H1 profit

Australian biotech company Peptech has announced a $137.7 million half yearly profit, a jump of 2,415 per cent on the previous year.
Yahoo!7 Business - 9:47 a.m. Thursday 17th May 2007

Coverage & Analysis View Article Email to Friend

1 year, 6 months ago Deal takes pep out of PepTech shares

Sydney biotech PepTech's plan to merge with antibody therapeutics company EvoGenix to "form one of Australia's largest biotechnology companies" received a mixed reaction yesterday, with the market lopping 5.7 per ...
The Age - 12:06 a.m. Tuesday 8th May 2007

Coverage & Analysis View Article Email to Friend

1 year, 6 months ago Peptech, EvoGenix merger to create giant

Drug maker Peptech Ltd is planning to merge with rival EvoGenix Ltd, in a $156 million deal.It will create one of the biggest biotechnology companies in Australia and a major ...
ninemsn Business News - 5:46 p.m. Monday 7th May 2007

Coverage & Analysis View Article Email to Friend

1 year, 8 months ago Peptech gets Citigroup help

BIOTECHNOLOGY group Peptech has appointed Citigroup to advise it on several approaches made by private equity firms and rival firms.
Herald Sun - 11:26 p.m. Wednesday 14th March 2007

Coverage & Analysis View Article Email to Friend

Peptech approached

BIOTECHNOLOGY company Peptech has appointed Citigroup to advise it on approaches by private-equity firms and other biotechnology companies.
Adelaide Now - 11:06 p.m. Wednesday 14th March 2007

Coverage & Analysis View Article Email to Friend

Australia's Peptech receives over 10 approaches

MELBOURNE, March 14 (Reuters) - Peptech Ltd. PTD.AX received at least 10 approaches, including from big drug makers, to take over or merge with the Australian biotech company worth A ...
Yahoo!7 Finance News - 4:56 p.m. Wednesday 14th March 2007

Coverage & Analysis View Article Email to Friend

Australia's Peptech taps Citigroup for sale advice

MELBOURNE, March 14 (Reuters) - Australia's Peptech Ltd. PTD.AX, with a market value of A $284 million ( $222 million), appointed Citigroup C.N to advise it after private equity firms ...
Yahoo!7 Finance News - 11:36 a.m. Wednesday 14th March 2007

Coverage & Analysis View Article Email to Friend

Peptech appoints advisor on approaches

Biotechnology company Peptech has appointed Citigroup to advise it on a number of approaches made by private equity firms and other biotechnology companies.
Yahoo!7 Business - 9:46 a.m. Wednesday 14th March 2007

Coverage & Analysis View Article Email to Friend

12 >